In response to the novel coronavirus (COVID-19) pandemic, the Vicks® family of cold and flu brands – NyQuil™, DayQuil™ and VapoRub™ – will donate $1 million to Direct Relief, one of the world’s largest medical relief organizations. These funds will go toward equipping front line health workers with protective gear and providing medicines and equipment needed to treat an anticipated spike in ICU patients. The organization is also working to expand medical assistance to safety-net health facilities where chronic gaps are expected to widen.
“Direct Relief is deeply grateful to Vicks for their leadership and generosity during this challenging time,” said Thomas Tighe, President and CEO of Direct Relief. “As cases continue to grow, private industry has an extraordinary ability to collaborate for the public good, and Vicks is leading by example.”
“As a leader in consumer health for more than 125 years, Vicks has always focused on providing care and promoting relief in times of need,” said Paul Gama, President-Elect, Global P&G Personal Health Care. “This time is no different – we must come together to help those most in need, which is why Vicks is helping to support health care workers on the front line.”
Direct Relief is a humanitarian aid organization that aims to improve the health and lives of people affected by poverty or emergencies, including COVID-19.